SCHEMBL7904537

SCHEMBL7904537

Nc1cccc2c(=O)ccnnc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 5/20 0.42
ELANE P08246 1/20 0.40
TDP1 Q9NUW8 4/20 0.38
ALDH1A1 P00352 4/20 0.38
HSD17B10 Q99714 3/20 0.38
CYP3A4 P08684 3/20 0.38
HPGD P15428 2/20 0.38
TSHR P16473 2/20 0.38
NR4A2 P43354 2/20 0.37
KDM4E B2RXH2 3/20 0.36
RECQL P46063 1/20 0.34
KEAP1 Q14145 1/20 0.33
MAPT P10636 2/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
APAF1 O14727 1/20 0.33
TDP2 O95551 1/20 0.33
CASP3 P42574 1/20 0.33
SENP8 Q96LD8 1/20 0.33
SENP7 Q9BQF6 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1765856 0.72 CYP3A4 (0.39) PARP1ELANETDP1ALDH1A1HSD17B10
SCHEMBL11270034 0.70 MAPT (0.48) ALDH1A1CYP3A4TSHRKDM4EMAPT
SCHEMBL1014701 0.68 GPR3 (0.48) PARP1TDP1ALDH1A1MEN1KMT2A
Hydrochloric Acid SCHEMBL6265298 0.67 GPR3 (0.46) PARP1TDP1ALDH1A1MEN1KMT2A
SCHEMBL28882668 0.66 CYP3A4 (0.33) PARP1TDP1ALDH1A1HSD17B10CYP3A4
SCHEMBL7904543 0.65 PARP1 (0.53) PARP1ELANETDP1ALDH1A1HSD17B10
SCHEMBL2008423 0.64 ALDH1A1 (0.50) TDP1ALDH1A1HSD17B10CYP3A4HPGD
SCHEMBL4703357 0.63
SCHEMBL29405609 0.63 GPR3 (0.58) PARP1TDP1ALDH1A1HSD17B10CYP3A4
SCHEMBL1869262 0.62 MAPT (0.39) PARP1TDP1ALDH1A1CYP3A4HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6201119-B1 2,3,4,5-TETRAHYDRO-1H-1,4-BENZODIAZEPIN-9-AMINE COMPOUNDS USEFUL AS INTERMEDIATES TO ANTIVIRALS JANSSEN PHARMACEUTICA N.V. (BE) 2001-03-13 US disclosed
EP-0417840-B1 Antiviral tetrahydroimidazo [1,4]-benzodiazepines JANSSEN PHARMACEUTICA NV (BE) 1994-12-07 EP disclosed
US-5371079-A Administering to inhibit replication of HIV-1 in human cells JANSSEN PHARMACEUTICA N.V. (BE) 1994-12-06 US disclosed
US-5270464-A Anti-HIV-1 tetrahydroimidazo[1,4]benzodiazepin-2-(thi) ones JANSSEN PHARMACEUTICA N.V. (BE) 1993-12-14 US disclosed
EP-0491751-A1 ANTIVIRAL TETRAHYDROIMIDAZO 1,4]BENZODIAZEPINES JANSSEN PHARMACEUTICA N.V. (BE) 1992-07-01 EP disclosed
WO-1991004255-A1 ANTIVIRAL TETRAHYDROIMIDAZO[1,4]BENZODIAZEPINES JANSSEN PHARMACEUTICA N.V. (BE) 1991-04-04 WO disclosed
EP-0417840-A1 Antiviral tetrahydroimidazo [1,4]-benzodiazepines JANSSEN PHARMACEUTICA N.V. (BE) 1991-03-20 EP disclosed